The US Patent and Trademark Office has granted a patent to Florida-based Valensa International covering its commercial its EyePro MD formula.
The formula includes lutein, zeaxanthin and astaxanthin mixed with omega-3 essential oils from krill, algae or perilla seed, said the company in a press release.
Patent No. 9,610,313, titled “Eye Health Composition and Method using Plant-Derived Seed Extract Rich in Essential Fatty Acids Derived from Perilla Seed and Carotenoids,” outlines the numerous health benefits this combination of all-natural, ingredients provides in EyePro MD. For example, the formula delivers macular carotenoid supplementation, phospholipids for enhanced bioavailability and omega-3 essential fatty acids known to support heart and cognitive functions.
“We have designed a small soft gel loaded with a potent combination of ingredients that can be absorbed efficiently to optimize eye health,” said Dr. John Minatelli, Senior Vice President of Business Development at Valensa. “Now with the patent IP in place, distributors and manufactures from the food and nutraceutical industry can include EyePro MD in their products knowing there’s nothing else like it on the market.”